未找到相关数据
Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS): Updated Results from a Phase 1b Study
被引：53
作者：
Brunner, Andrew M.
Esteve, Jordi
Porkka, Kimmo
Knapper, Steve
Vey, Norbert
Scholl, Sebastian
Garcia-Manero, Guillermo
Wermke, Martin
Janssen, Jeroen
Traer, Elie
Loo, Sun
Narayan, Rupa
Tovar, Natalia
Kontro, Mika
Ottmann, Oliver
Naidu, Purushotham
Kurtulus, Sema
Makofske, Jessica
Liao, Serena
Mohammed, Anisa
Sabatos-Peyton, Catherine A.
Rinne, Mikael L.
Borate, Uma
Wei, Andrew H.
机构：
来源：
关键词：
D O I：
10.1182/blood-2020-136855
中图分类号：
R5 [内科学];
学科分类号：
1002 ;
100201 ;
摘要：
引用
收藏
页数：5
相关论文